RCKT Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals Inc, formerly Inotek Pharmaceuticals Corp, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye.

$13.93  +0.02 (0.14%)
As of 06/24/2022 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/18/2015
Outstanding shares:  65,837,894
Average volume:  1,010,912
Market cap:   $915,805,106
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BDFKQ07
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.16
PS ratio:   0.00
Return on equity:   -41.16%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy